Literature DB >> 21474669

Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain.

Reto A Schuepbach1, Kara Velez, Matthias Riewald.   

Abstract

Thrombin and activated protein C (APC) signaling can mediate opposite biologic responses in endothelial cells. Given that thrombin induces procoagulant tissue factor (TF), we examined how TF activity is affected by APC. Exogenous or endogenously generated APC led to increased TF-dependent factor Xa activity. Induction required APC's proteolytic activity and binding to endothelial cell protein C receptor but not protease activated receptors. APC did not affect total TF antigen expression or the availability of anionic phospholipids on the apical cell membrane. Western blotting and cell surface immunoassays demonstrated that APC sheds the Kunitz 1 domain from tissue factor pathway inhibitor (TFPI). A TFPI Lys86Ala mutation between the Kunitz 1 and 2 domains eliminated both cleavage and the enhanced TF activity in response to APC in overexpression studies, indicating that APC up-regulates TF activity by endothelial cell protein C receptor-dependent shedding of the Kunitz 1 domain from membrane-associated TFPI. Our results demonstrate an unexpected procoagulant role of the protein C pathway that may have important implications for the regulation of TF- and TFPI-dependent biologic responses and for fine tuning of the hemostatic balance in the vascular system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474669      PMCID: PMC3122952          DOI: 10.1182/blood-2010-10-316257

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

Review 1.  Tissue factor encryption.

Authors:  Ronald R Bach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-05       Impact factor: 8.311

Review 2.  The cytoprotective protein C pathway.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

3.  A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression.

Authors:  S A Maroney; A C Cunningham; J Ferrel; R Hu; S Haberichter; C M Mansbach; R A Brodsky; D J Dietzen; A E Mast
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

4.  Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells.

Authors:  Clemens Feistritzer; Reto A Schuepbach; Laurent O Mosnier; Leslie A Bush; Enrico Di Cera; John H Griffin; Matthias Riewald
Journal:  J Biol Chem       Date:  2006-05-18       Impact factor: 5.157

Review 5.  The haemostatic role of tissue factor pathway inhibitor.

Authors:  James T B Crawley; David A Lane
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-19       Impact factor: 8.311

6.  Tissue factor activation: is disulfide bond switching a regulatory mechanism?

Authors:  Usha R Pendurthi; Samit Ghosh; Samir K Mandal; L Vijaya Mohan Rao
Journal:  Blood       Date:  2007-08-28       Impact factor: 22.113

Review 7.  Sources of tissue factor.

Authors:  Bjarne Østerud; Eirik Bjørklid
Journal:  Semin Thromb Hemost       Date:  2006-02       Impact factor: 4.180

8.  Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells.

Authors:  Xia V Yang; Yajnavalka Banerjee; José A Fernández; Hiroshi Deguchi; Xiao Xu; Laurent O Mosnier; Rolf T Urbanus; Phillip G de Groot; Tara C White-Adams; Owen J T McCarty; John H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-30       Impact factor: 11.205

9.  Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.

Authors:  Reto A Schuepbach; Clemens Feistritzer; Lawrence F Brass; Matthias Riewald
Journal:  Blood       Date:  2007-12-18       Impact factor: 22.113

10.  Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.

Authors:  Edward J Kerschen; José A Fernandez; Brian C Cooley; Xia V Yang; Rashmi Sood; Laurent O Mosnier; Francis J Castellino; Nigel Mackman; John H Griffin; Hartmut Weiler
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  6 in total

1.  Characterization of Skin Aging-Associated Secreted Proteins (SAASP) Produced by Dermal Fibroblasts Isolated from Intrinsically Aged Human Skin.

Authors:  Daniel M Waldera Lupa; Faiza Kalfalah; Kai Safferling; Petra Boukamp; Gereon Poschmann; Elena Volpi; Christine Götz-Rösch; Francoise Bernerd; Laura Haag; Ulrike Huebenthal; Ellen Fritsche; Fritz Boege; Niels Grabe; Julia Tigges; Kai Stühler; Jean Krutmann
Journal:  J Invest Dermatol       Date:  2015-03-27       Impact factor: 8.551

2.  Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Authors:  Sandip M Kanse; Paul J Declerck; Wolfram Ruf; George Broze; Michael Etscheid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

Review 3.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

4.  PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury.

Authors:  Karen De Ceunynck; Christian G Peters; Abhishek Jain; Sarah J Higgins; Omozuanvbo Aisiku; Jennifer L Fitch-Tewfik; Sharjeel A Chaudhry; Chris Dockendorff; Samir M Parikh; Donald E Ingber; Robert Flaumenhaft
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-17       Impact factor: 11.205

5.  TFPI1 mediates resistance to doxorubicin in breast cancer cells by inducing a hypoxic-like response.

Authors:  Gerald F Davies; Arnie Berg; Spike D L Postnikoff; Heather L Wilson; Terra G Arnason; Anthony Kusalik; Troy A A Harkness
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

6.  Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ.

Authors:  S A Maroney; P E Ellery; J P Wood; J P Ferrel; N D Martinez; A E Mast
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.